Cookson Peirce & Co’s STAAR Surgical STAA Stock Holding History

Cookson Peirce & Co’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,782	Closed	-$3.78M	–	239
2021 Q2	$3.78M	Buy	+24,782	New	+$3.26M	0.23%	82

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cookson Peirce & Co's STAA Position: Q3 2021 in Review

Cookson Peirce & Co sold out of STAAR Surgical (STAA) in Q3 2021, closing a stake of 24,782 shares — an estimated $3.78M sold.

Cookson Peirce & Co first reported a position in STAA in Q2 2021 and held it in 1 quarter. The position peaked at $3.78M in Q2 2021. 290 funds tracked by Wall St. Rank hold STAA as of Q3 2021.

Cookson Peirce & Co reported no remaining STAAR Surgical position as of Q3 2021 after selling out during the quarter.
Cookson Peirce & Co sold 24,782 STAAR Surgical shares in Q3 2021, an estimated $3.78M.
Cookson Peirce & Co first reported a position in STAAR Surgical in Q2 2021 and held it in 1 quarter.
Cookson Peirce & Co's STAAR Surgical position peaked at $3.78M in Q2 2021.
290 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2021.

Based on Cookson Peirce & Co's 13F filing for Q3 2021, filed 4 Nov 2021.